{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-034255","form_type":"8-K","ticker":null,"cik":"0001159281","company_name":"AlerisLife Inc.","filed_at":"2023-03-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.996213+00:00","generated_at":"2026-06-17T22:50:29.125625+00:00","sec_items":["1.01","3.01","3.03","5.01","5.02","5.03","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"AlerisLife completes $1.31/share take-private merger with ABP; shares delisted","bullets":["Tender offer expired March 17; 22.4M shares (66.9% outstanding) tendered at $1.31 cash per share.","Merger closed March 20; all remaining shares converted to $1.31 cash; AlerisLife is now wholly owned by ABP.","Offer price represents an 85% premium to 30-day average trading price prior to announcement.","Shares of ALR common stock ceased trading on Nasdaq; company to file Form 15 to suspend SEC reporting.","All directors (Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, Donna D. Fraiche) resigned effective at merger close."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-034255","json":"https://secwatch.observer/filing/0001104659-23-034255.json","markdown":"https://secwatch.observer/filing/0001104659-23-034255.md","text":"https://secwatch.observer/filing/0001104659-23-034255.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/tm238927d10_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T22:50:29.125625+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f19a97049","claim":"Barbara D. Gilmore resigned as Director at AlerisLife Inc..","evidence_excerpt":"Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"278eac88b3","claim":"Jennifer B. Clark resigned as Director at AlerisLife Inc..","evidence_excerpt":"Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"2d28bbe470","claim":"Gerard M. Martin resigned as Director at AlerisLife Inc..","evidence_excerpt":"Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7f69e6cf1b","claim":"Bruce M. Gans resigned as Director at AlerisLife Inc..","evidence_excerpt":"Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"9e07bc41dc","claim":"Donna D. Fraiche resigned as Director at AlerisLife Inc..","evidence_excerpt":"Barbara D. Gilmore, Jennifer B. Clark, Gerard M. Martin, Bruce M. Gans, and Donna D. Fraiche resigned as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8ceb1c5840bb3aad9c0ee77136b16c693515bf9f","claim":"AlerisLife Inc.: Amended and restated articles of incorporation in their entirety.","evidence_excerpt":"Pursuant to the terms of the Merger Agreement, as of the Effective Time, the Company’s amended and restated articles of incorporation were amended and restated in their entirety (the “Amended Articles of Incorporation”), and the Company’s amended and restated bylaws were amended and restated in their entirety (the “Amended Bylaws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"}],"fact_type":"governance_change"},{"claim_id":"9faff8ae8a2d7597e497318ce01340edcd1b2dba","claim":"AlerisLife Inc.: Amended and restated bylaws in their entirety.","evidence_excerpt":"Pursuant to the terms of the Merger Agreement, as of the Effective Time, the Company’s amended and restated articles of incorporation were amended and restated in their entirety (the “Amended Articles of Incorporation”), and the Company’s amended and restated bylaws were amended and restated in their entirety (the “Amended Bylaws”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"}],"fact_type":"governance_change"},{"claim_id":"1d52a65a3c7f91a04e15f5c2fc67634a3b2b32ee","claim":"AlerisLife Inc. underwent a change of control involving ABP for $1.31 per Share in cash (closed 2023-03-20).","evidence_excerpt":"any other direct or indirect wholly owned subsidiary of ABP or any person that owns, directly or indirectly, all of the outstanding equity interests of Purchaser) at a price of $1.31 per Share, net to the seller in cash, without interest, and subject to any applicable withholding of taxes (the “Offer Price”). At one minute after 11:59 p.m., Eastern Time, on","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"change of control"},{"label":"Counterparty","value":"ABP"},{"label":"Consideration","value":"$1.31 per Share in cash"},{"label":"Closing","value":"2023-03-20"}],"fact_type":"ma_transaction"},{"claim_id":"f75db534f69a09543e33b16ab841a24ffdffe60f","claim":"AlerisLife Inc. entered into Agreement and Plan of Merger with ABP Acquisition 2 LLC (effective 2023-02-02).","evidence_excerpt":"the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with ABP Acquisition 2 LLC (“Purchaser”), a Maryland limited liability company and a wholly-owned subsidiary of ABP Acquisition LLC (“ABP”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1159281/000110465923034255/0001104659-23-034255-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"ABP Acquisition 2 LLC"},{"label":"Effective","value":"2023-02-02"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}